Trade Marks AstraZeneca, the AstraZeneca logotype, and the AstraZeneca symbol are all trade marks of the Group.
The following brand names which appear in italics in this Annual Report are trade marks of the Group: Trade mark 1 3 Accolate Diprivan Movantik Seroquel XR Arimidex Duzallo Moventig Symbicort 3 7 Atacand EMLA Myalept Symbicort SMART 4 3 Atacand HCT Entocort Naropin Symbicort Turbuhaler Atacand Plus Farxiga Nexium Symlin 9 BCise Fasenra Nolvadex Synagis Bevespi Aerosphere Faslodex Onglyza Tagrisso 10 Bricanyl Fluenz Oxis Turbuhaler Tenormin Brilinta FluMist Plendil Toprol-XL Brilique Forxiga Pressair Turbuhaler Bydureon Genuair Prilosec Vimovo 5 Byetta Imdur Pulmicort Xigduo 3 Calquence Imfinzi Pulmicort Flexhaler Xylocaine 2 3 Caprelsa Iressa Pulmicort Respules Xylocard 3 3 Carbocaine Kombiglyze Pulmicort Turbuhaler Xyloproct 11 Casodex Komboglyze Qtern Zavicefta 3 10 Citanest Losec Respules Zestril 8 Cosudex Lynparza Rhinocort Zoladex 3 8 Crestor Marcaine Rhinocort Aqua Zomig 6 Daliresp Meronem Seloken Zurampic 6 Daxas Merrem Seroquel 1 AstraZeneca assigned this trade mark in the US to Par Pharmaceuticals Inc. effective 5 January 2015.
2 AstraZeneca assigned this trade mark to Genzyme Corporation effective 30 September 2015.
3 AstraZeneca divested these trade marks to Aspen group effective 1 November 2017.
4 AstraZeneca assigned this trade mark in the US to Elan Pharma International Limited effective 15 December 2015, and in the rest of the world to Tillots Pharma AG effective 16 July 2015.
5 AstraZeneca assigned this trade mark to Everest Future Limited effective 1 May 2016.
6 AstraZeneca assigned Meronem and Merrem to Pfizer Inc. in most markets outside the US effective 23 December 2016.
7 AstraZeneca assigned this trade mark to Aegerion effective 9 January 2015.
8 AstraZeneca assigned Rhinocort and Rhinocort Aqua to Cilag GmbH International outside the US effective 5 December 2016.
9 AstraZeneca owns this trade mark in the US only.
AbbVie owns it in the rest of the world.
10 AstraZeneca assigned these trade marks in the US to Alvogen Pharma US Inc. effective 9 January 2015.
11 AstraZeneca assigned this trade mark to Pfizer Inc. effective 23 December 2016.
The following brand names which appear in italics in this Annual Report are trade marks licensed to the Group by the entities set out below: Trade mark Licensor or Owner Duaklir Almirall, S. A. Eklira Almirall, S. A. Epanova Chrysalis Pharma AG Tudorza Almirall, S. A.
The following brand names which appear in italics throughout this Annual Report are not owned by or licensed to the Group and are owned by the entities set out below: Trade mark Owner Avastin Genentech, Inc. Darzalex Johnson & Johnson Keytruda MSD Lipitor Pfizer Ireland Pharmaceuticals messenger RNA Therapeutics Moderna Therapeutics, Inc. Vidaza Celgene Corporation 234 AstraZeneca Annual Report & Form 20-F Information 2017 Additional Information
